We are developing E-Plasters® to help “re-boot” the body’s natural bioelectric current to promote tissue healing/regeneration.
Our E-Plaster® digital platform with IoT connects patients and providers to improve productivity and quality of life.
Our proprietary catalogue of materials, BiomimInks™ enables us to offer bespoke solutions to repair/ rejuvenate a range of tissue types, as well as enable leading life-sciences research to explore cell/tissue behaviour in 3D biomimetic environment.
A person has a better chance of living five years with breast, prostate or colon cancer than a diabetic with a foot ulcer.
Guest et al; Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018; doi: 10.1136/bmjopen-2020-045253
NuTissu’s unique portfolio of photopolymers, BiomimInks® and biomaterials-based technology present a range of properties to completely and rapidly heal wounds, that include antimicrobial defence, skin epithelialisation, and crucially, enable the delivery of electrical-stimulation therapy with digital-health technologies through everyday consumer electronics.
Externally applied electric currents in wounded/damaged tissue can mimic the endogenous currents which facilitate wound healing. Our product, E-Plaster® with bioelectric stimulation aims to mimic this natural current of injury.
We are leveraging on IoT and digital health technologies to enable the solutions to be patient centric with the E-Plaster® App as well as enable our biomaterials to mimic optimal physiological functions with 3D printing.
Dr de Mel is the founder of NuTissu with 10+ years of experience following her doctorate in Tissue Engineering and Regenerative Medicine, has been executing projects in surgical MedTech and related. She brings a unique approach to solving wounds combining biomaterials, bioelectricity and digital health technology.
Stephen Carter is Founder of The Intellectual Property Works, an intellectual property consultancy. He is a UK and European Patent Attorney with over 25 years’ experience and is recognised by IAM300 as a leading IP strategist. Having spent many years as a partner in two London-based law firms, Stephen now acts as an advisor to innovative start-ups and SMEs.
Professor Steven Jeffery is a Consultant Burns and Plastic Surgeon and is Professor of Wound Study and Birmingham City University. He has extensive experience of complex wound management and is also an Internal Clinician for BSI.
Dr Gabriel Ma is a senior clinical strategist and clinical safety officer at The AbedGraham Group, leading risk and compliance consultancy services. A former psychiatrist, he has covered clinical safety, cybersecurity and ISO standard alignment for startups to some of the largest global companies
Antonio is a versatile, and highly experienced Full-Stack developer with over 20 years of experience in Software Development and passion for software architectures.
Avira is a graduate in Computer Science and Engineering (BTech) and has 8+ years experience as a Software Engineer/Full-Stack Developer in a range of domains including projects supporting workflows & automating patient engagement, and has contributed to the development of cutting-edge applications across the globe.
Heidi is an Honorary Fellow with a clinical background in tissue viability nursing, working for Hertfordshire Community NHS Trust and independently. She has won an award for the Chief Nursing Officer Gold award for services to tissue viability in 2020.
NuTissu has successfully completed Phase 1 of the Health Innovation Award they received for the E-Plaster® development in 2023, from the Office for Veterans and
Biological patterns of life are the “visible expression of an underlying bioelectrical pattern” Sinnott, 1960. Electrical currents, carried by mobile charged ions, within cellular environment
Minister for Veterans’ Affairs Johnny Mercer joined with Nutissu staff to announce Veterans Health Innovation Fund awards aiming to improve the UK’s capability to save
There is an unmet need for artificial tissue to address current limitations with donor organs and problems with donor site morbidity. Despite the
If you are interested in what we are doing please get in touch
If you have experience (at least 8 yrs following graduate studies) either in fields of engineering, materials, data or digital technologies please get in touch.
![lab[98]](https://nutissu.com/wp-content/uploads/2023/05/lab98.jpg)
Westbourne Studios, 242, Acklam Road, London, W10 5JJ
© NuTissu Limited. All rights reserved.
